A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
- 30 June 2004
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 16 (1), 110-123
- https://doi.org/10.1016/j.nbd.2004.01.007
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Time course of striatal ΔFosB‐like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatmentEuropean Journal of Neuroscience, 2003
- Mining the mouse genomeNature, 2002
- Animal models of neurological deficits: how relevant is the rat?Nature Reviews Neuroscience, 2002
- Astrocyte Delivery of Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's DiseaseExperimental Neurology, 2002
- cAMP Response Element-Binding Protein Is Required for Dopamine-Dependent Gene Expression in the Intact But Not the Dopamine-Denervated StriatumJournal of Neuroscience, 2001
- Neuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson's DiseaseJournal of Neuroscience, 2001
- Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's DiseaseNeurobiology of Disease, 1999
- Levodopa therapyNeurology, 1998
- Risk Factors for Peak Dose Dyskinesia in 100 Levodopa-treated Parkinsonian PatientsCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1996
- Sequence and expression of the rat prodynorphin gene.Proceedings of the National Academy of Sciences of the United States of America, 1985